Zogenix, Inc. (NASDAQ:ZGNX)

Tcw05452 (31.48) Submitted: 4/27/2013 8:38:58 PM : Start Price: $1.63 ZGNX Score: -12.23

Recent FDA decision makes short term shaky at best. However, once a tamper proof delivery mechanism is added to the formulation of Zohydro, it will be one of the top prescribed medications in the US.

jungleboi313 (< 20) Submitted: 3/10/2013 3:03:32 PM : Start Price: $1.75 ZGNX Score: -20.99

drug approval chances are very high. full 2012 financial results to be announced Fri, 15th. Even if dont approved, price wont go down dramatically.

Vapor09 (49.34) Submitted: 3/3/2013 1:16:39 AM : Start Price: $1.88 ZGNX Score: -29.42

Pain killer approval

TMFMattyA (99.70) Submitted: 12/10/2012 2:50:01 PM : Start Price: $1.20 ZGNX Score: -8.65

I was once a small proponent of this company, but the recent FDA decision seriously hinders Zogenix's market-beating potential, at least for the next year or so.

Lennyg02 (< 20) Submitted: 5/24/2012 6:05:18 PM : Start Price: $1.69 ZGNX Score: -36.34

Hype of Zohydro will give this stock a healthy raise, but I don't see too many physicians prescribing a ridiculously addictive drug.

RBuskey106 (29.99) Submitted: 4/4/2012 12:56:04 PM : Start Price: $2.02 ZGNX Score: -44.43

Chart Play